LATITUDE Psoriasis Studies

Steer Your
psoriasis
sympstoms
In the Right Direction.

If your [plaque] psoriasis journey feels like a trip with no destination,

it may be time to explore a different path. The LATITUDE Psoriasis Studies are evaluating an investigational oral treatment for adults with moderate to severe [plaque] psoriasis.

You may be able to participate in the LATITUDE Psoriasis Studies if you:

Are 18 years of age or older
Have been diagnosed with moderate to severe psoriasis for at least 6 months
Are interested in an investigational oral treatment
Have no prior use of the standard-of-care treatment

If you are interested in participating, the study doctor or staff will review additional study criteria with you.

Qualified participants will receive all study-related medications and study-related care at no cost. Participants may be compensated for travel and expenses. [Health insurance is not required to participate.]

About the LATITUDE Psoriasis Studies

Embrace the future of psoriasis care with the LATITUDE Psoriasis Studies. This program is evaluating an investigational oral treatment for adults with moderate to severe [plaque] psoriasis.

The investigational treatment works by helping to control inflammatory signals known to contribute to the buildup of [plaque] psoriasis.

Participants will receive the investigational treatment, standard-of-care treatment, or a placebo (a substance that looks like the investigational treatment but does not contain any active ingredients) while completing various study tests and procedures. 

Over the duration of the study, participants may have the opportunity to change treatments to receive the investigational treatment or standard-of-care treatment. The study treatment will be given as an oral pill.

Neither participants nor the study staff will know if participants are receiving the investigational treatment, standard-of-care treatment, or a placebo. Participants will attend up to 20 scheduled study visits over the course of about a year. 

© 2023–2024 Clinical Trial Media. All Rights Reserved.

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences. 

For more detailed information on the cookies we use, please check our Privacy Policy

By continuing to access this website, you are giving us consent to collect cookies.